序号 |
标题 |
次数 |
作者 |
发布时间 |
74476 |
CAS号:2055041-40-0 , Azido-PEG1-Val-Cit-PAB-OH |
91 |
WYQ |
2024-12-18 |
74477 |
cas:1226006-55-8,N-(2-(3-Ethoxyphenoxy)ethyl)-4-formylbenzamide, ADC试剂 |
68 |
kx |
2024-12-18 |
74478 |
DOTA-LTVSPWY 双功能螯合剂DOTA偶联肽LTVSPWY |
73 |
h |
2024-12-18 |
74479 |
CAS号:2055024-65-0 ,Azido-PEG3-Val-Cit-PAB-OH |
78 |
WYQ |
2024-12-18 |
74480 |
DOTA-CCK-66 大环DOTA偶联CCK2R靶向化合物CCK-66 |
180 |
h |
2024-12-18 |
74481 |
cas:1228153-04-5,4-Formyl-N-(2-(naphthalen-2-yloxy)ethyl)benzamide |
105 |
kx |
2024-12-18 |
74482 |
抗DOTA IgG-scFv BsAb anti-DOTA IgG-scFv BsAb |
120 |
h |
2024-12-18 |
74483 |
cas:1226217-30-6,4-Formyl-N-(2-(4-isopropylphenoxy)ethyl)benzamide |
81 |
kx |
2024-12-18 |
74484 |
DOTA-rL-A9肽 DOTA偶联核定位序列(NLS)-移植的her 2-受体亲和肽 |
99 |
h |
2024-12-18 |
74485 |
cas:796073-59-1,2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate |
71 |
kx |
2024-12-18 |
74486 |
DOTA-E[c(RGDFK)]2 双功能螯合剂偶联的RGD多肽E[c(RGDfK)]2 |
76 |
h |
2024-12-18 |
74487 |
DBCO-C4-Val-Cit-PABC-PNP,分子式:C46H49N7O10 |
80 |
WYQ |
2024-12-18 |
74488 |
DBCO-(PEG)3-VC-PAB-MMAE,CAS号:57103-68-1 |
55 |
WYQ |
2024-12-18 |
74489 |
cas:1134280-65-1,2,5-Dioxopyrrolidin-1-yl 3-((2,4-difluorobenzyl)oxy)propanoate |
78 |
kx |
2024-12-18 |
74490 |
DBCO-PEG3-acetic-Val-Cit-PAB(二苯并环辛炔) |
84 |
WYQ |
2024-12-18 |
74491 |
cas:1824718-79-7,SPDH, ADC试剂 |
85 |
kx |
2024-12-18 |
74492 |
cas:1232769-29-7,2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate |
88 |
kx |
2024-12-18 |
74493 |
Amino-PEG2-VG-N-Bis(PEG1-azide),氨基-二聚乙二醇-VG-N-双(一聚乙二醇-叠氮) |
126 |
WYQ |
2024-12-18 |
74494 |
Alkyne-Val-Cit-PAB-FAM,炔-VAL-CIT-PAB-FAM |
73 |
WYQ |
2024-12-18 |
74495 |
cas:1226218-43-4,4-Formyl-N-(2-(2,3,6-trimethylphenoxy)ethyl)benzamide |
69 |
kx |
2024-12-18 |
74496 |
双功能螫合剂DOTA偶联MAG3 DOTA-MAG3 |
107 |
h |
2024-12-18 |
74497 |
Alkyne-Val-Cit-PAB-PNP,炔-Val-Cit-PAB-PNP |
86 |
WYQ |
2024-12-18 |
74498 |
DOTA-MSH2 金属螯合剂DOTA偶联二聚体肽(MSH2) |
94 |
h |
2024-12-18 |
74499 |
cas:796073-64-8,(S)-2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate |
71 |
kx |
2024-12-18 |
74500 |
N,N-二乙基正辛硫基乙酰胺,(N,N-Diethyl-α-(OctlyThio)-Acetamide)简称DOTA |
72 |
h |
2024-12-18 |
74501 |
cas:437655-95-3,Fmoc-NH-PEG4-CH2COOH, 5,8,11,14-四氧杂-2-氮杂十六碳二酸 1-芴甲基酯 |
82 |
kx |
2024-12-18 |
74502 |
Val-Ala-PAB-OH |
104 |
zyl |
2024-12-18 |
74503 |
DOTA-Bz-Cys-RGD dimer 双功能螯合剂修饰Cys-RGD dimer |
82 |
h |
2024-12-18 |
74504 |
cas:874208-92-1,m-PEG7-NHS ester, ADC试剂 |
92 |
kx |
2024-12-18 |
74505 |
Boc-PEG4-Val-Ala-PAB-PNP |
86 |
zyl |
2024-12-18 |
74506 |
111 In-奥曲肽(Octreo Scan) |
323 |
h |
2024-12-18 |
74507 |
POSS-DOTA 大环配体DOTA偶联七异丁基-氨丙基六面体倍半硅氧烷POSS |
83 |
h |
2024-12-18 |
74508 |
cas:164332-88-1,N-Boc-PEG1-bromide, [2-(2-溴乙氧基)乙基]氨基甲酸叔丁酯 |
65 |
kx |
2024-12-18 |
74509 |
DOTA-Substance P DOTA-SP |
96 |
h |
2024-12-18 |
74510 |
Mal-amido-PEG8-val-gly-PAB-OH CAS:2353409-52-4 |
84 |
zyl |
2024-12-18 |
74511 |
FITC-Gly-Gly-Gly-CBT |
76 |
h |
2024-12-18 |
74512 |
FITC-Gly-Gly-Gly-CBT |
103 |
h |
2024-12-18 |
74513 |
FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne,荧光素类染料的一种 |
117 |
WYQ |
2024-12-18 |
74514 |
cas:98604-88-7,Bis-SS-C3-NHS ester, ADC试剂 |
92 |
kx |
2024-12-18 |
74515 |
DOTA-钆特酸葡甲胺 Gd-DOTA |
163 |
h |
2024-12-18 |
74516 |
MAL-tri-EG-OPFP的介绍 |
114 |
zyl |
2024-12-18 |
74517 |
NH2-PEG-NH2 氨基-聚乙二醇-氨基 |
92 |
h |
2024-12-18 |
74518 |
cas:1884578-00-0,Boc-Val-Ala-PAB-PNP |
83 |
kx |
2024-12-18 |
74519 |
CAS号为1613321-01-9的6-Azidohexanoyl-Val-Cit-PAB |
81 |
WYQ |
2024-12-18 |
74520 |
聚乙二醇PEG-DOTA修饰超支化聚乙烯亚胺 PEI-PEG-DOTA |
105 |
h |
2024-12-18 |